Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.

Phase 2 Completed 119 enrolled Eli Lilly and Company Alkermes, Inc. · collab

RandomizedCrossoverOpen-labelTreatment

Summary

This is a research study of a study drug known as LY041001 or human insulin inhalation powder (HIIP). HIIP is a powder form of insulin made to be inhaled through the mouth and into the lungs using a special handheld device.

Timeline

Start: 2003-04
Primary completion: —
Completion: 2004-04

Publications

Hayes RP, Muchmore D, Schmitke J. Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes. Curr Med Res Opin. 2007 Feb;23(2):435-42. doi: 10.1185/030079906X167381.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Insulin	Protein / enzyme biologic	2 iu	Subcutaneous
Comparator	Insulin	Protein / enzyme biologic	6 iu	Subcutaneous
Subject	Insulin Lispro	Protein / enzyme biologic	—	Subcutaneous

Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.

Summary

Timeline

Publications

Drugs

Indications